TGFB1 and non-small cell lung carcinoma: To maximize the inhibitory effects of fucoidan on cell migration and invasion activity in NSCLC (e.g., A549 and CL1-5 cells), the cells were stimulated with TGFβ, which has been shown to activate TGFRs relevant to oncogenic signaling in tumor mobility.